1-8 of 8
Sylvia Bellucci
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Complete Hematological, Molecular and Histological Remissions without Cytoreductive Treatment Lasting After Pegylated-Interferon α-2a (peg-IFNα-2a) Therapy in Polycythemia Vera (PV): Long Term Results of a Phase 2 Trial

Pascal Turlure, MD, Nathalie Cambier, MD, Murielle Roussel, Sylvia Bellucci, MD, PhD, Jean-Marc Zini, MD, PhD, Jean-Didier Rain, MD, Philippe Rousselot, MD, PhD, William Vainchenker, MD, PhD, Lina Abdelkader, Kamel Ghomari, Jean-Luc Dutel, Yasmine Chait, Sylvie Chevret, Christine Chomienne, MD, PhD, Bruno Cassinat, PharmD, Jean-Jacques Kiladjian, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 280.
https://doi.org/10.1182/blood.V118.21.280.280
Published: 2011
Journal Articles

The JAK2 46/1 haplotype in splanchnic vein thrombosis

Eirini Kouroupi, Jean-Jacques Kiladjian, Christine Chomienne, Christine Dosquet, Sylvia Bellucci, Dominique Valla, Bruno Cassinat
Journal: Blood
Blood (2011) 117 (21): 5777–5778.
https://doi.org/10.1182/blood-2011-03-343657
Published: 2011
Journal Articles

Lack of Association Between the 46/1 JAK2 Haplotype and the Presence of JAK2V617F Mutation In Splanchnic Vein Thrombosis Patients

Eirini G Kouroupi, MD, Bruno Cassinat, PharmD, Aurelie Plessier, MD, Sylvia Bellucci, MD, Christine Chomienne, MD, PhD, Bernard Granchamp, MD, PhD, Dominique Valla, MD, PhD, Jean-Jacques Kiladjian, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 4120.
https://doi.org/10.1182/blood.V116.21.4120.4120
Published: 2010
Journal Articles

Pegylated interferon-alfa-2a induces complete hematologic and molecular responses with low toxicity in polycythemia vera

Clinical Trials & Observations
Jean-Jacques Kiladjian, Bruno Cassinat, Sylvie Chevret, Pascal Turlure, Nathalie Cambier, Murielle Roussel, Sylvia Bellucci, Bernard Grandchamp, Christine Chomienne, Pierre Fenaux
Journal: Blood
Blood (2008) 112 (8): 3065–3072.
https://doi.org/10.1182/blood-2008-03-143537
Published: 2008
Journal Articles

Peg IFNα-2a in Polycythemia Vera (PV). Results of a Phase 2 Study by the French “PV-NORD” Group.

Jean-Jacques Kiladjian, MD, Bruno Cassinat, MD, Pascal Turlure, MD, Nathalie Cambier, MD, Sylvia Bellucci, MD,PhD, Murielle Roussel, MD, Marie-José Grange, MD, Bernard Grandchamp, MD,PhD, Jean-Didier Rain, MD,PhD, Christine Chomienne, MD,PhD, Pierre Fenaux, MD,PhD
Journal: Blood
Blood (2006) 108 (11): 670.
https://doi.org/10.1182/blood.V108.11.670.670
Published: 2006
Journal Articles

High molecular response rate of polycythemia vera patients treated with pegylated interferon α–2a

Clinical Trials & Observations Brief Report
Jean-Jacques Kiladjian, Bruno Cassinat, Pascal Turlure, Nathalie Cambier, Murielle Roussel, Sylvia Bellucci, Marie-Laurence Menot, Gerald Massonnet, Jean-Luc Dutel, Kamel Ghomari, Philippe Rousselot, Marie-Jose Grange, Yasmina Chait, William Vainchenker, Nathalie Parquet, Lina Abdelkader-Aljassem, Jean-François Bernard, Jean-Didier Rain, Sylvie Chevret, Christine Chomienne, Pierre Fenaux
Journal: Blood
Blood (2006) 108 (6): 2037–2040.
https://doi.org/10.1182/blood-2006-03-009860
Published: 2006
Journal Articles

PVN1: A Phase 2 Study of Pegylated Interferon-α2a in Polycythemia Vera (PV) by the “PV-Nord” Group. Preliminary Report of Efficacy and Safety.

Jean-Jacques Kiladjian, MD, Bruno Cassinat, MD, Pascal Turlure, MD, Sylvia Bellucci, MD, Nathalie Cambier, MD, Murielle Roussel, MD, Marie-José Grange, MD, Jean-Didier Rain, MD, Christine Chomienne, MD, Pierre Fenaux, MD
Journal: Blood
Blood (2005) 106 (11): 4940.
https://doi.org/10.1182/blood.V106.11.4940.4940
Published: 2005
Journal Articles

Severe Proximal Deep Vein Thrombosis in a Glanzmann Thrombasthenia Variant Successfully Treated With a Low Molecular Weight Heparin

Yves Gruel, Gérard Pacouret, Sylvia Bellucci, Jacques Caen
Journal: Blood
Blood (1997) 90 (2): 888–889.
https://doi.org/10.1182/blood.V90.2.888
Published: 1997